B. Braun Focused on Vascular Access, Patient and Healthcare Worker Safety

April 28, 2014

Safety Engineered IV Therapy Portfolio to be showcased at INS

BETHLEHEM, Pa., April 28, 2014 /PRNewswire/ — B. Braun Medical Inc. (B.Braun) will sponsor an Exhibitor Theater presentation and simulation lab at the Infusion Nursing Society (INS) 2014 Annual Convention and Industrial Exhibition in Phoenix, AZ, May 3(rd)-8(th). The presentation, “Navigating the Depths: Ultrasound Guided Short PIV Insertions–Implications and Limitations for Practice,” will feature a discussion of technology and procedures related to ultrasound guided peripheral IV insertion that highlights standardized approaches to patient assessment and techniques for vessel access.

Dr. Robert B. Dawson, DNP, MSA, APRN, ACNP–BC, CPUI, VA-BC, Vascular Access Consultant, PICC Academy, will be the featured presenter during B.Braun’s Clinical Excellence Series. The presentation will take place on Tuesday, May 6(th) at 10:10 am -11:00 am in Exhibitor Theater B, which is located in the back of the 800 aisle of the Industrial Exhibition. The simulation lab will also take place on Tuesday, May 6(th), at 12:30 pm -1:30 pm in the Simulation Lab*, which is located in the back of the 500 aisle of the Industrial Exhibition.

Click here for an audio Podcast presentation preview of Robert Dawson.

Catheter-related bloodstream infections (CRBSIs), needlestick (sharps) injuries and exposure to potentially deadly blood borne pathogens continue to be major issues facing all healthcare professionals.

“B.Braun is committed to combating these issues by providing innovative safety-engineered IV therapy devices that offer patient protection against infection and optimum safety for clinicians in the workplace,” said Tom Sutton, Vice President of Vascular Access Systems at B.Braun.

B.Braun will demonstrate its family of safety-engineered IV therapy devices at booth (#615) during INS:

    --  Introcan Safety(®) IV Catheter, which is designed with innovative
        passive-safety features to help eliminate accidental needlestick injury
        - effortlessly. From insertion to catheter deployment to needle removal,
        clinicians are protected by a truly passive safety device that is
        activated automatically - no extra steps required and cannot be
    --  Introcan Safety(®) 3 Closed IV Catheter, B.Braun's latest innovation,
        which takes the same preferred passive safety-engineered needlestick
        protection found in Introcan Safety and adds additional protection from
        blood exposure. For safety and convenience, the Introcan Safety 3's
        unique multi-access blood control septum minimizes blood exposure during
        needle removal and each time the catheter hub is accessed.
    --  Caresite(®) Luer Access Device, the latest in B.Braun's needleless
        connector portfolio that offers a safe way to access IV lines without
        the use of a needle, which reduces the risk of accidental needlestick
        injuries. Input from clinicians provided the basis for the CARESITE
        design. The result is a device designed to help improve patient outcomes
        and clinician efficiency. CARESITE needleless connector with innovative
        positive displacement feature is designed to help reduce catheter
        occlusions while preventing healthcare workers from accidental
        needlestick injuries.

B.Braun also offers devices to help ensure healthcare worker safety and protect them from exposure to hazardous drugs, which is growing at an alarming rate. To learn more visit B.Braun’s Cytotoxic Exposure Information page at www.CytotoxicExposure.com

About B. Braun

B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its “Sharing Expertise(®)” philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, B.Braun Interventional Systems, Aesculap(®) and CAPS(®). B.Braun’s U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 50,000 employees in more than 60 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.

*Due to the hands-on nature of the simulation lab learning experience, attendance at the Exhibitor Theater presentation is a prerequisite for attending the Simulation Lab. Space in the simulation lab is limited to 40 participants.

SOURCE B. Braun Medical Inc.

Source: PR Newswire

comments powered by Disqus